Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glucosamine, chondroitin

This article was originally published in The Tan Sheet

Executive Summary

Joint supplement ingredients nominated by National Cancer Institute for toxicological testing due to their "widespread long-term use as a dietary supplement and inadequate data to assess safety," National Toxicology Program announces in July 16 Federal Register notice. Proposed testing includes chronic toxicity and carcinogenicity review. Trans-Resveratrol nominated for testing by the National Institute of Environmental Health Sciences based on "widespread human exposure from natural dietary sources and use of dietary supplements." Studies on potential reproductive toxicity, toxicological characterization, carcinogenicity advised. Deadline for comments on nominations due at Sept. 15...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095739

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel